Floatz logo

Nimodipine

Post-stroke Dementia

Yuzhen PanSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Post-stroke Dementia cohort.

Asset / SponsorPhaseRating
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE
Chang Gung Memorial Hospital
Phase 2BB
THK-5351
Chang Gung Memorial Hospital
Phase 2B

Same molecule, other indications

Nimodipine is also rated in:

stroke disorderDormant
BB
Indicative ·
68 / 100
View asset →
reversible cerebral vasoconstriction syndromeDormant
BB
Indicative ·
64 / 100
View asset →
cerebral infarctionDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →